Overview

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of the trial is to investigate the bioequivalence (the expected biological equivalence of two pharmaceutical drug products with identical active ingredient) of Norditropin® (somatropin) versus Genotropin® (somatropin) in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S